179 related articles for article (PubMed ID: 29082496)
1. High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines.
Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Grandis JR
Methods Mol Biol; 2018; 1683():229-244. PubMed ID: 29082496
[TBL] [Abstract][Full Text] [Related]
2. High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.
Johnston PA; Sen M; Hua Y; Camarco D; Shun TY; Lazo JS; Grandis JR
Assay Drug Dev Technol; 2014; 12(1):55-79. PubMed ID: 24127660
[TBL] [Abstract][Full Text] [Related]
3. HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.
Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Wilson GM; Resnick LO; LaPorte MG; Wipf P; Huryn DM; Grandis JR
Assay Drug Dev Technol; 2015 Sep; 13(7):356-76. PubMed ID: 26317883
[TBL] [Abstract][Full Text] [Related]
4. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.
Ouédraogo ZG; Müller-Barthélémy M; Kemeny JL; Dedieu V; Biau J; Khalil T; Raoelfils LI; Granzotto A; Pereira B; Beaudoin C; Guissou IP; Berger M; Morel L; Chautard E; Verrelle P
Brain Pathol; 2016 Jan; 26(1):18-30. PubMed ID: 25736961
[TBL] [Abstract][Full Text] [Related]
6. Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.
Peyser ND; Pendleton K; Gooding WE; Lui VW; Johnson DE; Grandis JR
PLoS One; 2016; 11(11):e0166185. PubMed ID: 27855189
[TBL] [Abstract][Full Text] [Related]
7. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
[TBL] [Abstract][Full Text] [Related]
8. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
[TBL] [Abstract][Full Text] [Related]
9. Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways.
Corsetti G; Yuan Z; Romano C; Chen-Scarabelli C; Fanzani A; Pasini E; Dioguardi FS; Onorati F; Linardi D; Knight R; Patel H; Faggian G; Saravolatz L; Scarabelli TM
Med Sci Monit Basic Res; 2019 May; 25():139-152. PubMed ID: 31073117
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG; Saba NF
Head Neck Pathol; 2019 Sep; 13(3):304-312. PubMed ID: 30191505
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract][Full Text] [Related]
12. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
13. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
Berishaj M; Gao SP; Ahmed S; Leslie K; Al-Ahmadie H; Gerald WL; Bornmann W; Bromberg JF
Breast Cancer Res; 2007; 9(3):R32. PubMed ID: 17531096
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway.
Zhao M; Li Y; Xiao W
Int J Rheum Dis; 2017 Feb; 20(2):214-224. PubMed ID: 27493089
[TBL] [Abstract][Full Text] [Related]
15. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
[TBL] [Abstract][Full Text] [Related]
16. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
[TBL] [Abstract][Full Text] [Related]
17. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
18. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.
Lapeire L; Hendrix A; Lambein K; Van Bockstal M; Braems G; Van Den Broecke R; Limame R; Mestdagh P; Vandesompele J; Vanhove C; Maynard D; Lehuédé C; Muller C; Valet P; Gespach CP; Bracke M; Cocquyt V; Denys H; De Wever O
Cancer Res; 2014 Dec; 74(23):6806-19. PubMed ID: 25252914
[TBL] [Abstract][Full Text] [Related]
20. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]